Blau Farmacêutica S.A. (BVMF:BLAU3)
8.78
+0.07 (0.80%)
Jul 29, 2026, 5:03 PM GMT-3
Blau Farmacêutica Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Blau Farmacêutica stock has a consensus rating of "Hold" and an average price target of R$12.26. The average 1-year stock price forecast is 39.64% higher than the current stock price, while the lowest is R$9.00 (+2.51%) and the highest is R$17.00 (+93.62%).
Price Target: R$12.26 (+39.64%)
Analyst Consensus: Hold
Price Target
ChartAnalyst Ratings
The average analyst rating for Blau Farmacêutica stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 7 | 7 | 7 | 7 | 7 | 7 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 1 |
| Total | 10 | 10 | 10 | 10 | 11 | 11 |
Financial Forecast
Revenue This Year
1.95B
from 1.70B
Increased by 14.40%
Revenue Next Year
2.21B
from 1.95B
Increased by 13.59%
EPS This Year
1.22
from 1.02
Increased by 20.48%
EPS Next Year
1.40
from 1.22
Increased by 14.61%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is BRL.